Grufity logo
Grufity logo

Latest General Catalyst Group Management, LLC Stock Portfolio

$188Million | No. of Holdings #14

General Catalyst Group Management, LLC Performance

2026 Q2+16.97%
YTD-5.58%
2025-31.21%

About General Catalyst Group Management, LLC and 13F Hedge Fund Stock Holdings

General Catalyst Group Management, LLC is a hedge fund based in Cambridge, MA. On 2026-08-17, the fund reported it's updated stock portfolio. In the 13F Holdings report, General Catalyst Group Management, LLC reported an equity portfolio of $188.5 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of General Catalyst Group Management, LLC are , , . The fund has invested 27.6% of it's portfolio in ARRIVENT BIOPHARMA, INC. and 23.2% of portfolio in PARABILIS MEDICINES, INC. <br><br> The fund managers got completely rid off SAMSARA INC (IOT) and GITLAB INC (GTLB) stocks. They significantly reduced their stock positions in FRACTYL HEALTH, INC.. General Catalyst Group Management, LLC opened new stock positions in PARABILIS MEDICINES, INC., DOORDASH INC. (DASH) and CARVANA CO (CVNA). The fund showed a lot of confidence in some stocks as they added substantially to META PLATFORMS INC. (META), AMAZON.COM INC. (AMZN) and COUPANG INC. (CPNG).
General Catalyst Group Management, LLC Equity Portfolio Value
Last Reported on: 17 Aug, 2026
$188Million
  as of Aug 17, 2026

General Catalyst Group Management, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that General Catalyst Group Management, LLC made a return of 16.97% in the last quarter. In trailing 12 months, it's portfolio return was -26.5%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
parabilis medicines, inc.43,817,600
odyssey therapeutics, inc. 15,160,200
doordash inc. 525,911
carvana co425,526
New stocks bought by General Catalyst Group Management, LLC

Additions

Ticker% Inc.
meta platforms inc. 100
amazon.com inc.50.35
coupang inc. 49.08
Additions to existing portfolio by General Catalyst Group Management, LLC

Reductions

Ticker% Reduced
fractyl health, inc. 0.00
General Catalyst Group Management, LLC reduced stake in above stock

Sold off

Ticker$ Sold
samsara inc-63,380,000
gitlab inc-19,939,200
General Catalyst Group Management, LLC got rid off the above stocks

Sector Distribution

General Catalyst Group Management, LLC has about 98.1% of it's holdings in Others sector.

  • Others
  • Consumer Cyclical
Sector%
Others98.1
Consumer Cyclical1.2

Market Cap. Distribution

General Catalyst Group Management, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

  • UNALLOCATED
Category%
UNALLOCATED98.1

Stocks belong to which Index?

About 0% of the stocks held by General Catalyst Group Management, LLC either belong to S&P 500 or RUSSELL 2000 index.

  • Others
Index%
Others98.9
Top 5 Winners (%)%
fractyl health, inc.
73.5 %
ethos technologies, inc.
62.4 %
arrivent biopharma, inc.
50.6 %
maplebear, inc.
26.4 %
eikon therapeutics, inc.
23.4 %
Top 5 Winners ($)$
arrivent biopharma, inc.
17.4 M
maplebear, inc.
7.0 M
fractyl health, inc.
1.6 M
eikon therapeutics, inc.
0.8 M
ethos technologies, inc.
0.5 M
Top 5 Losers (%)%
figma, inc.
-14.4 %
CPNG
coupang inc.
-6.8 %
META
meta platforms inc.
-1.2 %
maze therapeutics, inc.
-0.0 %
Top 5 Losers ($)$
CPNG
coupang inc.
-0.1 M
figma, inc.
0.0 M
maze therapeutics, inc.
0.0 M
META
meta platforms inc.
0.0 M

General Catalyst Group Management, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of General Catalyst Group Management, LLC

General Catalyst Group Management, LLC has 14 stocks in it's portfolio. About 99% of the portfolio is in top 10 stocks. CPNG proved to be the most loss making stock for the portfolio. was the most profitable stock for General Catalyst Group Management, LLC last quarter.

$188.52MTotal Value
16.00Positions
17 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of General Catalyst Group Management, LLC, last reported on 17 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
Com
Arrivent Biopharma, Inc.

Arrivent Biopharma, Inc.

General Catalyst Group Management, LLC's holding in Arrivent Biopharma, Inc. over time
27.55%1,494,790
$51.93M
27.55%
unchanged 0 percentunchanged
Com
Parabilis Medicines, Inc.

Parabilis Medicines, Inc.

General Catalyst Group Management, LLC's holding in Parabilis Medicines, Inc. over time
23.24%1,600,940
$43.82M
23.24%
new position
Com
Maplebear, Inc.

Maplebear, Inc.

General Catalyst Group Management, LLC's holding in Maplebear, Inc. over time
17.85%710,711
$33.65M
17.85%
unchanged 0 percentunchanged
Com
Maze Therapeutics, Inc.

Maze Therapeutics, Inc.

General Catalyst Group Management, LLC's holding in Maze Therapeutics, Inc. over time
16.4%1,035,910
$30.91M
16.4%
unchanged 0 percentunchanged
Common Stock
Odyssey Therapeutics, Inc.

Odyssey Therapeutics, Inc.

General Catalyst Group Management, LLC's holding in Odyssey Therapeutics, Inc. over time
8.04%810,272
$15.16M
8.04%
new position
Com
Eikon Therapeutics, Inc.

Eikon Therapeutics, Inc.

General Catalyst Group Management, LLC's holding in Eikon Therapeutics, Inc. over time
2.11%305,233
$3.98M
2.11%
unchanged 0 percentunchanged
Com
Fractyl Health, Inc.

Fractyl Health, Inc.

General Catalyst Group Management, LLC's holding in Fractyl Health, Inc. over time
2.06%4,884,190
$3.88M
2.06%
unchanged 0 percentreduced
Cl A
Ethos Technologies, Inc.

Ethos Technologies, Inc.

General Catalyst Group Management, LLC's holding in Ethos Technologies, Inc. over time
0.71%74,179
$1.35M
0.71%
unchanged 0 percentunchanged
Class A Com Stk
Figma, Inc.

Figma, Inc.

General Catalyst Group Management, LLC's holding in Figma, Inc. over time
0.14%14,845
$268.5K
0.14%
unchanged 0 percentunchanged